http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2262882-C1

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-10
filingDate 2004-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2005-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_219b4adc0ad94ed98876ed6441403053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc6209577a2fc0334f33b059c2b604d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31dbcda6eaafd0ad2d285ebb8c4ea032
publicationDate 2005-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2262882-C1
titleOfInvention Method for determining primary open angle glaucoma treatment tactics
abstract FIELD: medicine. n SUBSTANCE: method involves recording 2-3 trains of general electroretinograms with growing retina flash exposure between the trains from 1000 to 3000 mccandela/m 2 when treating patient in horizontal and anti-orthostatic position at the same time on both eyes. Amplitude-time factors are determined on the produced electroretinograms like absolute values of a- and b-waves on general electroretinogram, a- and b-wave latent period values on general electroretinogram, averaged a- and b-wave amplitude on general electroretinogram, in adjacent electroretinogram trains (ERG-coefficient). The values being equal to each other or less than a half of values violating reference value threshold for both patient positions or not less than a half of amplitude-time factor values violating reference value threshold in on of patient positions, conservative therapy is indicated. Not less than a half of values violating statistical norm in both patient positions, eye state is considered to be decompensed and surgical treatment is advised to be administered. n EFFECT: high accuracy in determining treatment tactics. n 6 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2681705-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2603326-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2681935-C1
priorityDate 2004-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918515
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452892474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426122273
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449751587

Total number of triples: 27.